Liquiritin Alleviates Pain Through Inhibiting CXCL1/CXCR2 Signaling Pathway in Bone Cancer Pain Rat-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liquiritin Alleviates Pain Through Inhibiting CXCL1/CXCR2 Signaling Pathway in Bone Cancer Pain Rat

Published:2020-04-24 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Ni Huadong,Xu Miao,Xie Keyue,Fei Yong,Deng Housheng,He Qiuli,Wang Tingting,Liu Songlei,Zhu Jianjun,Xu Longsheng,Yao Ming

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference48 articles.

1. Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer;Akoury;J. Cancer Cell International,2019

2. Extracellular caspase-6 drives murine inflammatory pain via microglial TNF-alpha secretion;Berta;J. Clin. Invest.,2014

3. Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2;Cao;Exp. Neurol.,2014

4. Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain;Carreira;Eur. J. Pain,2013

5. Liquiritin potentiate neurite outgrowth induced by nerve growth factor in PC12 cells;Chen;Cytotechnology,2009

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquiritin ameliorates painful diabetic neuropathy in SD rats by inhibiting NLRP3-MMP-9-mediated reversal of aquaporin-4 polarity in the glymphatic system;Frontiers in Pharmacology;2024-09-04

2. The Anticancer Journey of Liquiritin: Insights into Its Mechanisms and Therapeutic Prospects;Current Medicinal Chemistry;2024-08-19

3. Liquiritin alleviates LPS-stimulated podocyte apoptosis and inflammation by activating Nrf2 signaling;Molecular & Cellular Toxicology;2024-05-14

4. Curcumin analogue NL04 inhibits spinal cord central sensitization in rats with bone cancer pain by inhibiting NLRP3 inflammasome activation and reducing IL-1β production;European Journal of Pharmacology;2024-05

5. Integration of serum pharmacochemistry and metabolomics to reveal the underlying mechanism of shaoyao-gancao-fuzi decoction to ameliorate rheumatoid arthritis;Journal of Ethnopharmacology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3